FDA Import Refusal 1FX-8099523-5/30002/2 — IPCA LABS
The FDA refused shipment 1FX-8099523-5/30002/2 from IPCA LABS (India) on May 15, 2026. The refused product falls under Drugs and Biologics — LOSARTAN POTASSIUM (ANTI-HYPERTENSIVE - PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- May 15, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62OCA41 LOSARTAN POTASSIUM (ANTI-HYPERTENSIVE - PART II)
- Charges
- 75